EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Andras Fogarasi, Liesbeth De Waele, Gabriella Bartalini, Sergiusz Jozwiak, Nicola Laforgia, Helene Verhelst, Borivoj Petrak, Jean-Michel Pedespan, Olaf Witt, Ramon Castellana, Stefania Crippa, Gabriella Gislimberti, Zsuzsanna Gyorsok

ABSTRACT

BACKGROUND: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be effective and safe in the treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC). The Everolimus For Fast Expanded aCcess in TSC SEGA (EFFECTS) study was designed to provide everolimus access to patients with SEGA associated with TSC and to mainly assess the safety and also efficacy of everolimus in a real-world setting. METHODS: EFFECTS was a phase 3b, open-label, noncomparative, multicenter, expanded access study. Eligible patients were ≥ 3 years of age, with a definite diagnosis of TSC, and with at least one SEGA lesion identified by MRI or CT scan. Patients received once daily everolimus (dose adjusted to attain a trough level of 5-15 ng/mL). Safety evaluation was the primary objective and included collection of adverse events (AEs) and serious AEs, with their severity and relationship to everolimus. Efficacy evaluation, which was the secondary objective, was based on the best overall response as per medical judgment. RESULTS: Of the 120 patients enrolled, 100 (83.3%) completed the study. Median age of patients was 11 years (range, 1-47). Median daily dose of everolimus was 5.82 mg (range, 2.0-11.8). Median duration of exposure was 56.5 weeks (range, 0.3-130). The overall incidence of AEs was 74.2%. Aphthous stomatitis (18 [15.0%]), pyrexia (18 [15.0%]), bronchitis (11 [9.2%]), and stomatitis (10 [8.3%]) were the most common AEs reported. Overall, 25 patients had grade 3 AEs; most frequent was stomatitis (4 [3.3%]). Grade 4 AEs were reported in three (2.5%) patients. A total of 62 (51.7%) patients had suspected drug-related AEs, of which 15 (12.5%) were of grade 3 or 4. In eight (6.7%) patients, AEs led to drug discontinuation. With regard to efficacy, 81 (67.5%) patients had a partial response, 35 (29.2%) had a stable disease, and one (0.8%) had progressive disease. The response was unknown in three (2.5%) patients. CONCLUSION: This study confirms the acceptable safety profile of everolimus in patients with SEGA associated with TSC in a real-world setting. The results further support the efficacy of everolimus in the treatment of SEGA associated with TSC. (EudraCT: 2010-022583-13). More... »

PAGES

126

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4

DOI

http://dx.doi.org/10.1186/s12883-016-0658-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026098504

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27502586


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Astrocytoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bronchitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Everolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fever", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomatitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomatitis, Aphthous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tuberous Sclerosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Bethesda Gyermekk\u00f3rh\u00e1z", 
          "id": "https://www.grid.ac/institutes/grid.427987.7", 
          "name": [
            "Neurology Department, Bethesda Children\u2019s Hospital, Bethesda Street 3, H-1146, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fogarasi", 
        "givenName": "Andras", 
        "id": "sg:person.0717700043.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717700043.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universitaire Ziekenhuizen Leuven", 
          "id": "https://www.grid.ac/institutes/grid.410569.f", 
          "name": [
            "Gasthuisberg University Hospitals Leuven, Leuven, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Waele", 
        "givenName": "Liesbeth", 
        "id": "sg:person.01344505207.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344505207.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Senese", 
          "id": "https://www.grid.ac/institutes/grid.411477.0", 
          "name": [
            "Pediatric Unit, University Hospital, Siena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bartalini", 
        "givenName": "Gabriella", 
        "id": "sg:person.01076001116.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076001116.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical University of Warsaw", 
          "id": "https://www.grid.ac/institutes/grid.13339.3b", 
          "name": [
            "Children\u2019s Memorial Health Institute, Warsaw, Poland", 
            "Department of Pediatric Neurology, Medical University of Warsaw, Warsaw, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jozwiak", 
        "givenName": "Sergiusz", 
        "id": "sg:person.0761055735.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055735.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bari Aldo Moro", 
          "id": "https://www.grid.ac/institutes/grid.7644.1", 
          "name": [
            "Neonatology and NICU Section, DIMO, University of Bari, Bari, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laforgia", 
        "givenName": "Nicola", 
        "id": "sg:person.0600321213.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600321213.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ghent University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410566.0", 
          "name": [
            "Ghent University Hospital, Ghent, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verhelst", 
        "givenName": "Helene", 
        "id": "sg:person.0665477047.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665477047.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital in Motol", 
          "id": "https://www.grid.ac/institutes/grid.412826.b", 
          "name": [
            "Motol University Hospital, Prague, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrak", 
        "givenName": "Borivoj", 
        "id": "sg:person.01313336275.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313336275.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Bordeaux", 
          "id": "https://www.grid.ac/institutes/grid.42399.35", 
          "name": [
            "CHU Pellegrin\u2013H\u00f4pital des Enfants, Bordeaux, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pedespan", 
        "givenName": "Jean-Michel", 
        "id": "sg:person.0731716626.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731716626.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "German Cancer Research Center and Section of Pediatric Brain Tumors, University Hospital, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Witt", 
        "givenName": "Olaf", 
        "id": "sg:person.01367420407.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367420407.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Spain)", 
          "id": "https://www.grid.ac/institutes/grid.476612.0", 
          "name": [
            "Novartis Farmac\u00e9utica SA, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castellana", 
        "givenName": "Ramon", 
        "id": "sg:person.016513102705.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016513102705.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Italy)", 
          "id": "https://www.grid.ac/institutes/grid.15585.3c", 
          "name": [
            "Novartis Farma S.p.A., Origgio, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crippa", 
        "givenName": "Stefania", 
        "id": "sg:person.010010031505.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010010031505.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Italy)", 
          "id": "https://www.grid.ac/institutes/grid.15585.3c", 
          "name": [
            "Novartis Farma S.p.A., Origgio, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gislimberti", 
        "givenName": "Gabriella", 
        "id": "sg:person.01145056405.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145056405.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bethesda Gyermekk\u00f3rh\u00e1z", 
          "id": "https://www.grid.ac/institutes/grid.427987.7", 
          "name": [
            "Neurology Department, Bethesda Children\u2019s Hospital, Bethesda Street 3, H-1146, Budapest, Hungary", 
            "National Institute of Neurosciences, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gyorsok", 
        "givenName": "Zsuzsanna", 
        "id": "sg:person.01317050103.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317050103.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1100391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002019704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-0445", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003978738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpn.2012.12.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006752995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00301665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007024239", 
          "https://doi.org/10.1007/bf00301665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/088307389801301206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012252699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/088307389801301206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012252699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2012.02.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012443339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/b978-0-444-52891-9.00038-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013632066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpn.2013.03.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015822271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.08.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017921616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61134-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019518465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.08.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024394203"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra055323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028026275"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(08)61279-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028138958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpn.2012.10.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028768098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1001671", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029275718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2013.281053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031488893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20784", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032399558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20784", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032399558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00381-013-2170-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033912792", 
          "https://doi.org/10.1007/s00381-013-2170-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71101-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034717349"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.12.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036207371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)70489-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038475260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039003462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tem.2010.05.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045995641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61767-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047847005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.23960", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048919715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0030-1269906", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057233391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000142039.14522.1a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000142039.14522.1a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000142039.14522.1a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/157015912804143595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078738365"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be effective and safe in the treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC). The Everolimus For Fast Expanded aCcess in TSC SEGA (EFFECTS) study was designed to provide everolimus access to patients with SEGA associated with TSC and to mainly assess the safety and also efficacy of everolimus in a real-world setting.\nMETHODS: EFFECTS was a phase 3b, open-label, noncomparative, multicenter, expanded access study. Eligible patients were \u2265 3 years of age, with a definite diagnosis of TSC, and with at least one SEGA lesion identified by MRI or CT scan. Patients received once daily everolimus (dose adjusted to attain a trough level of 5-15 ng/mL). Safety evaluation was the primary objective and included collection of adverse events (AEs) and serious AEs, with their severity and relationship to everolimus. Efficacy evaluation, which was the secondary objective, was based on the best overall response as per medical judgment.\nRESULTS: Of the 120 patients enrolled, 100 (83.3%) completed the study. Median age of patients was 11 years (range, 1-47). Median daily dose of everolimus was 5.82 mg (range, 2.0-11.8). Median duration of exposure was 56.5 weeks (range, 0.3-130). The overall incidence of AEs was 74.2%. Aphthous stomatitis (18 [15.0%]), pyrexia (18 [15.0%]), bronchitis (11 [9.2%]), and stomatitis (10 [8.3%]) were the most common AEs reported. Overall, 25 patients had grade 3 AEs; most frequent was stomatitis (4 [3.3%]). Grade 4 AEs were reported in three (2.5%) patients. A total of 62 (51.7%) patients had suspected drug-related AEs, of which 15 (12.5%) were of grade 3 or 4. In eight (6.7%) patients, AEs led to drug discontinuation. With regard to efficacy, 81 (67.5%) patients had a partial response, 35 (29.2%) had a stable disease, and one (0.8%) had progressive disease. The response was unknown in three (2.5%) patients.\nCONCLUSION: This study confirms the acceptable safety profile of everolimus in patients with SEGA associated with TSC in a real-world setting. The results further support the efficacy of everolimus in the treatment of SEGA associated with TSC. (EudraCT: 2010-022583-13).", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12883-016-0658-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024950", 
        "issn": [
          "1471-2377"
        ], 
        "name": "BMC Neurology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex", 
    "pagination": "126", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7c54c9bd92ec8ec44f057d7e66a30cde1e0ba80ae9fd258382374f999a55b645"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27502586"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968555"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12883-016-0658-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026098504"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12883-016-0658-4", 
      "https://app.dimensions.ai/details/publication/pub.1026098504"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87088_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12883-016-0658-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'


 

This table displays all metadata directly associated to this object as RDF triples.

367 TRIPLES      21 PREDICATES      82 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12883-016-0658-4 schema:about N0511ccb66e6e49f0b4f9ab89a029ec69
2 N0b27ad8239704861a6f8ef74e49129f5
3 N100fdd15e88348feb1e3090c6e1904a2
4 N27dc0c1dfc5e4ad5a6986e88faa8e148
5 N4f19314470bf49c896e5446d4dc8123c
6 N5fe478c75e90492189eea1eae16ada6b
7 N66a03235418c44a096558caad65c2fc0
8 N69701025ba75448782303e7fb363f76d
9 N6c89f318ca2546eda157abef8c71ee70
10 N7a0aef070ee64f2ca17318b3c76d7be2
11 N81f185ffa5ca4f68b376eace6ecb0ba3
12 N8324c760369e4911afb006b29a393116
13 N89718d6630cf4990ac77b4f4e316c47e
14 N8ea6d3d1b90d41cfac34167f7b15d922
15 Naa55818f64844b6fae9bf65350093fa8
16 Nb8f1021e552e4d3f8f3d00c5f9a6bfa9
17 Nd66cedcce78c4d498d56e72d906c0d86
18 Ndb29fa1281914280ae90961285718d99
19 Ne2ba6bc521eb4c6e9d0e93b578ca22c4
20 Nedcc67ab189944c694e51f30feeb8b3b
21 Nf0e39a584bc54e7ab90079f3fc0f5a0d
22 Nf4a93c593d4746bc9de271a087210431
23 Nfcf6c4bf84614ebf8817a91d2cb0ce40
24 anzsrc-for:11
25 anzsrc-for:1117
26 schema:author N2ab6c8ee6cab47e48dc502c0efeca725
27 schema:citation sg:pub.10.1007/bf00301665
28 sg:pub.10.1007/s00381-013-2170-0
29 https://doi.org/10.1001/jama.2013.281053
30 https://doi.org/10.1002/ana.20784
31 https://doi.org/10.1002/ana.23960
32 https://doi.org/10.1016/b978-0-444-52891-9.00038-5
33 https://doi.org/10.1016/j.ejpn.2012.10.005
34 https://doi.org/10.1016/j.ejpn.2012.12.008
35 https://doi.org/10.1016/j.ejpn.2013.03.002
36 https://doi.org/10.1016/j.pediatrneurol.2012.02.015
37 https://doi.org/10.1016/j.pediatrneurol.2013.08.001
38 https://doi.org/10.1016/j.pediatrneurol.2013.08.002
39 https://doi.org/10.1016/j.pediatrneurol.2013.08.017
40 https://doi.org/10.1016/j.pediatrneurol.2013.12.004
41 https://doi.org/10.1016/j.tem.2010.05.003
42 https://doi.org/10.1016/s0140-6736(08)61279-9
43 https://doi.org/10.1016/s0140-6736(12)61134-9
44 https://doi.org/10.1016/s0140-6736(12)61767-x
45 https://doi.org/10.1016/s1470-2045(14)70489-9
46 https://doi.org/10.1016/s1470-2045(14)71101-5
47 https://doi.org/10.1055/s-0030-1269906
48 https://doi.org/10.1056/nejmoa1001671
49 https://doi.org/10.1056/nejmoa1100391
50 https://doi.org/10.1056/nejmra055323
51 https://doi.org/10.1158/1078-0432.ccr-11-0445
52 https://doi.org/10.1177/088307389801301206
53 https://doi.org/10.1212/01.wnl.0000142039.14522.1a
54 https://doi.org/10.1212/wnl.0b013e3182815428
55 https://doi.org/10.2174/157015912804143595
56 https://doi.org/10.3171/2013.9.peds13193
57 schema:datePublished 2016-12
58 schema:datePublishedReg 2016-12-01
59 schema:description BACKGROUND: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be effective and safe in the treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC). The Everolimus For Fast Expanded aCcess in TSC SEGA (EFFECTS) study was designed to provide everolimus access to patients with SEGA associated with TSC and to mainly assess the safety and also efficacy of everolimus in a real-world setting. METHODS: EFFECTS was a phase 3b, open-label, noncomparative, multicenter, expanded access study. Eligible patients were ≥ 3 years of age, with a definite diagnosis of TSC, and with at least one SEGA lesion identified by MRI or CT scan. Patients received once daily everolimus (dose adjusted to attain a trough level of 5-15 ng/mL). Safety evaluation was the primary objective and included collection of adverse events (AEs) and serious AEs, with their severity and relationship to everolimus. Efficacy evaluation, which was the secondary objective, was based on the best overall response as per medical judgment. RESULTS: Of the 120 patients enrolled, 100 (83.3%) completed the study. Median age of patients was 11 years (range, 1-47). Median daily dose of everolimus was 5.82 mg (range, 2.0-11.8). Median duration of exposure was 56.5 weeks (range, 0.3-130). The overall incidence of AEs was 74.2%. Aphthous stomatitis (18 [15.0%]), pyrexia (18 [15.0%]), bronchitis (11 [9.2%]), and stomatitis (10 [8.3%]) were the most common AEs reported. Overall, 25 patients had grade 3 AEs; most frequent was stomatitis (4 [3.3%]). Grade 4 AEs were reported in three (2.5%) patients. A total of 62 (51.7%) patients had suspected drug-related AEs, of which 15 (12.5%) were of grade 3 or 4. In eight (6.7%) patients, AEs led to drug discontinuation. With regard to efficacy, 81 (67.5%) patients had a partial response, 35 (29.2%) had a stable disease, and one (0.8%) had progressive disease. The response was unknown in three (2.5%) patients. CONCLUSION: This study confirms the acceptable safety profile of everolimus in patients with SEGA associated with TSC in a real-world setting. The results further support the efficacy of everolimus in the treatment of SEGA associated with TSC. (EudraCT: 2010-022583-13).
60 schema:genre research_article
61 schema:inLanguage en
62 schema:isAccessibleForFree true
63 schema:isPartOf N560ec1a01cd9438a9e9d91c538c1798e
64 Ne416109b2d25465786ab55af588ec3cf
65 sg:journal.1024950
66 schema:name EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
67 schema:pagination 126
68 schema:productId N470dac5dd5314a9c95e1341a513c63df
69 N5215e223db024b9487d3b79ade3f20df
70 N72fd9474e0c34cd79e12ef01ae57a57e
71 Nb69d09f67dc74148a290f95fe0661477
72 Nd437b61d53194fff8e509ff281c3421a
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026098504
74 https://doi.org/10.1186/s12883-016-0658-4
75 schema:sdDatePublished 2019-04-11T12:22
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher N3f32b903299c49c9a15826963e5df346
78 schema:url https://link.springer.com/10.1186%2Fs12883-016-0658-4
79 sgo:license sg:explorer/license/
80 sgo:sdDataset articles
81 rdf:type schema:ScholarlyArticle
82 N0511ccb66e6e49f0b4f9ab89a029ec69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Adolescent
84 rdf:type schema:DefinedTerm
85 N08011def549946d3a3641f525930f90d rdf:first sg:person.0761055735.36
86 rdf:rest N2c7bf2e9aeb3484e95a6216cc31fbe63
87 N086c3f1acf6f4a988c7a2e27a59443d2 rdf:first sg:person.01344505207.04
88 rdf:rest N9d4cc5c1d2494508905cbc59cb39b653
89 N0b27ad8239704861a6f8ef74e49129f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Astrocytoma
91 rdf:type schema:DefinedTerm
92 N100fdd15e88348feb1e3090c6e1904a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Adult
94 rdf:type schema:DefinedTerm
95 N13a970f203b040e7be34dc6b5ba241bc rdf:first sg:person.0731716626.13
96 rdf:rest Ne0c1f1a2e9ce41dbb22478382d9359e2
97 N15dfce57da404ca8b2f92d6cf2525fe6 schema:name German Cancer Research Center and Section of Pediatric Brain Tumors, University Hospital, Heidelberg, Germany
98 rdf:type schema:Organization
99 N25faf1d48e48414ab94ab39775e98f84 rdf:first sg:person.01313336275.27
100 rdf:rest N13a970f203b040e7be34dc6b5ba241bc
101 N27dc0c1dfc5e4ad5a6986e88faa8e148 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Everolimus
103 rdf:type schema:DefinedTerm
104 N2ab6c8ee6cab47e48dc502c0efeca725 rdf:first sg:person.0717700043.03
105 rdf:rest N086c3f1acf6f4a988c7a2e27a59443d2
106 N2c7bf2e9aeb3484e95a6216cc31fbe63 rdf:first sg:person.0600321213.94
107 rdf:rest N5a656e9b6d3943ba8dd36ef490feec8a
108 N3f32b903299c49c9a15826963e5df346 schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N470dac5dd5314a9c95e1341a513c63df schema:name dimensions_id
111 schema:value pub.1026098504
112 rdf:type schema:PropertyValue
113 N475a060577ab4e1fae3ab7443ede532a rdf:first sg:person.010010031505.70
114 rdf:rest Nf61cdff504ae4875a4c99c879f993c32
115 N4f19314470bf49c896e5446d4dc8123c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Remission Induction
117 rdf:type schema:DefinedTerm
118 N5215e223db024b9487d3b79ade3f20df schema:name pubmed_id
119 schema:value 27502586
120 rdf:type schema:PropertyValue
121 N560ec1a01cd9438a9e9d91c538c1798e schema:volumeNumber 16
122 rdf:type schema:PublicationVolume
123 N5a656e9b6d3943ba8dd36ef490feec8a rdf:first sg:person.0665477047.21
124 rdf:rest N25faf1d48e48414ab94ab39775e98f84
125 N5fe478c75e90492189eea1eae16ada6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Disease Progression
127 rdf:type schema:DefinedTerm
128 N66a03235418c44a096558caad65c2fc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Bronchitis
130 rdf:type schema:DefinedTerm
131 N69701025ba75448782303e7fb363f76d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Brain Neoplasms
133 rdf:type schema:DefinedTerm
134 N6c89f318ca2546eda157abef8c71ee70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Safety
136 rdf:type schema:DefinedTerm
137 N72fd9474e0c34cd79e12ef01ae57a57e schema:name nlm_unique_id
138 schema:value 100968555
139 rdf:type schema:PropertyValue
140 N7a0aef070ee64f2ca17318b3c76d7be2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 N7b98dc8e3b9e4634852bda851cedd295 rdf:first sg:person.016513102705.92
144 rdf:rest N475a060577ab4e1fae3ab7443ede532a
145 N81f185ffa5ca4f68b376eace6ecb0ba3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Treatment Outcome
147 rdf:type schema:DefinedTerm
148 N8324c760369e4911afb006b29a393116 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Stomatitis, Aphthous
150 rdf:type schema:DefinedTerm
151 N89718d6630cf4990ac77b4f4e316c47e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Young Adult
153 rdf:type schema:DefinedTerm
154 N8ea6d3d1b90d41cfac34167f7b15d922 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Stomatitis
156 rdf:type schema:DefinedTerm
157 N9adeef23b8ce4218ab6677227d785168 rdf:first sg:person.01317050103.52
158 rdf:rest rdf:nil
159 N9d4cc5c1d2494508905cbc59cb39b653 rdf:first sg:person.01076001116.87
160 rdf:rest N08011def549946d3a3641f525930f90d
161 Naa55818f64844b6fae9bf65350093fa8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Female
163 rdf:type schema:DefinedTerm
164 Nb69d09f67dc74148a290f95fe0661477 schema:name doi
165 schema:value 10.1186/s12883-016-0658-4
166 rdf:type schema:PropertyValue
167 Nb8f1021e552e4d3f8f3d00c5f9a6bfa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Child
169 rdf:type schema:DefinedTerm
170 Nd437b61d53194fff8e509ff281c3421a schema:name readcube_id
171 schema:value 7c54c9bd92ec8ec44f057d7e66a30cde1e0ba80ae9fd258382374f999a55b645
172 rdf:type schema:PropertyValue
173 Nd66cedcce78c4d498d56e72d906c0d86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Fever
175 rdf:type schema:DefinedTerm
176 Ndb29fa1281914280ae90961285718d99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Child, Preschool
178 rdf:type schema:DefinedTerm
179 Ne0c1f1a2e9ce41dbb22478382d9359e2 rdf:first sg:person.01367420407.26
180 rdf:rest N7b98dc8e3b9e4634852bda851cedd295
181 Ne2ba6bc521eb4c6e9d0e93b578ca22c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Infant
183 rdf:type schema:DefinedTerm
184 Ne416109b2d25465786ab55af588ec3cf schema:issueNumber 1
185 rdf:type schema:PublicationIssue
186 Nedcc67ab189944c694e51f30feeb8b3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Middle Aged
188 rdf:type schema:DefinedTerm
189 Nf0e39a584bc54e7ab90079f3fc0f5a0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Antineoplastic Agents
191 rdf:type schema:DefinedTerm
192 Nf4a93c593d4746bc9de271a087210431 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Tuberous Sclerosis
194 rdf:type schema:DefinedTerm
195 Nf61cdff504ae4875a4c99c879f993c32 rdf:first sg:person.01145056405.34
196 rdf:rest N9adeef23b8ce4218ab6677227d785168
197 Nfcf6c4bf84614ebf8817a91d2cb0ce40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Humans
199 rdf:type schema:DefinedTerm
200 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
201 schema:name Medical and Health Sciences
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
204 schema:name Public Health and Health Services
205 rdf:type schema:DefinedTerm
206 sg:journal.1024950 schema:issn 1471-2377
207 schema:name BMC Neurology
208 rdf:type schema:Periodical
209 sg:person.010010031505.70 schema:affiliation https://www.grid.ac/institutes/grid.15585.3c
210 schema:familyName Crippa
211 schema:givenName Stefania
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010010031505.70
213 rdf:type schema:Person
214 sg:person.01076001116.87 schema:affiliation https://www.grid.ac/institutes/grid.411477.0
215 schema:familyName Bartalini
216 schema:givenName Gabriella
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076001116.87
218 rdf:type schema:Person
219 sg:person.01145056405.34 schema:affiliation https://www.grid.ac/institutes/grid.15585.3c
220 schema:familyName Gislimberti
221 schema:givenName Gabriella
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145056405.34
223 rdf:type schema:Person
224 sg:person.01313336275.27 schema:affiliation https://www.grid.ac/institutes/grid.412826.b
225 schema:familyName Petrak
226 schema:givenName Borivoj
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313336275.27
228 rdf:type schema:Person
229 sg:person.01317050103.52 schema:affiliation https://www.grid.ac/institutes/grid.427987.7
230 schema:familyName Gyorsok
231 schema:givenName Zsuzsanna
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317050103.52
233 rdf:type schema:Person
234 sg:person.01344505207.04 schema:affiliation https://www.grid.ac/institutes/grid.410569.f
235 schema:familyName De Waele
236 schema:givenName Liesbeth
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344505207.04
238 rdf:type schema:Person
239 sg:person.01367420407.26 schema:affiliation N15dfce57da404ca8b2f92d6cf2525fe6
240 schema:familyName Witt
241 schema:givenName Olaf
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367420407.26
243 rdf:type schema:Person
244 sg:person.016513102705.92 schema:affiliation https://www.grid.ac/institutes/grid.476612.0
245 schema:familyName Castellana
246 schema:givenName Ramon
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016513102705.92
248 rdf:type schema:Person
249 sg:person.0600321213.94 schema:affiliation https://www.grid.ac/institutes/grid.7644.1
250 schema:familyName Laforgia
251 schema:givenName Nicola
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600321213.94
253 rdf:type schema:Person
254 sg:person.0665477047.21 schema:affiliation https://www.grid.ac/institutes/grid.410566.0
255 schema:familyName Verhelst
256 schema:givenName Helene
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665477047.21
258 rdf:type schema:Person
259 sg:person.0717700043.03 schema:affiliation https://www.grid.ac/institutes/grid.427987.7
260 schema:familyName Fogarasi
261 schema:givenName Andras
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717700043.03
263 rdf:type schema:Person
264 sg:person.0731716626.13 schema:affiliation https://www.grid.ac/institutes/grid.42399.35
265 schema:familyName Pedespan
266 schema:givenName Jean-Michel
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731716626.13
268 rdf:type schema:Person
269 sg:person.0761055735.36 schema:affiliation https://www.grid.ac/institutes/grid.13339.3b
270 schema:familyName Jozwiak
271 schema:givenName Sergiusz
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055735.36
273 rdf:type schema:Person
274 sg:pub.10.1007/bf00301665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007024239
275 https://doi.org/10.1007/bf00301665
276 rdf:type schema:CreativeWork
277 sg:pub.10.1007/s00381-013-2170-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033912792
278 https://doi.org/10.1007/s00381-013-2170-0
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1001/jama.2013.281053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031488893
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1002/ana.20784 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032399558
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1002/ana.23960 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048919715
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/b978-0-444-52891-9.00038-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013632066
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.ejpn.2012.10.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028768098
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/j.ejpn.2012.12.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006752995
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/j.ejpn.2013.03.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015822271
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/j.pediatrneurol.2012.02.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012443339
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1016/j.pediatrneurol.2013.08.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024394203
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1016/j.pediatrneurol.2013.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039003462
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/j.pediatrneurol.2013.08.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017921616
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/j.pediatrneurol.2013.12.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036207371
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1016/j.tem.2010.05.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045995641
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1016/s0140-6736(08)61279-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028138958
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1016/s0140-6736(12)61134-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019518465
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1016/s0140-6736(12)61767-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1047847005
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1016/s1470-2045(14)70489-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038475260
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1016/s1470-2045(14)71101-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034717349
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1055/s-0030-1269906 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057233391
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1056/nejmoa1001671 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029275718
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1056/nejmoa1100391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002019704
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1056/nejmra055323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028026275
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1158/1078-0432.ccr-11-0445 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003978738
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1177/088307389801301206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012252699
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1212/01.wnl.0000142039.14522.1a schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346426
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1212/wnl.0b013e3182815428 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064357524
331 rdf:type schema:CreativeWork
332 https://doi.org/10.2174/157015912804143595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078738365
333 rdf:type schema:CreativeWork
334 https://doi.org/10.3171/2013.9.peds13193 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071079237
335 rdf:type schema:CreativeWork
336 https://www.grid.ac/institutes/grid.13339.3b schema:alternateName Medical University of Warsaw
337 schema:name Children’s Memorial Health Institute, Warsaw, Poland
338 Department of Pediatric Neurology, Medical University of Warsaw, Warsaw, Poland
339 rdf:type schema:Organization
340 https://www.grid.ac/institutes/grid.15585.3c schema:alternateName Novartis (Italy)
341 schema:name Novartis Farma S.p.A., Origgio, Italy
342 rdf:type schema:Organization
343 https://www.grid.ac/institutes/grid.410566.0 schema:alternateName Ghent University Hospital
344 schema:name Ghent University Hospital, Ghent, Belgium
345 rdf:type schema:Organization
346 https://www.grid.ac/institutes/grid.410569.f schema:alternateName Universitaire Ziekenhuizen Leuven
347 schema:name Gasthuisberg University Hospitals Leuven, Leuven, Belgium
348 rdf:type schema:Organization
349 https://www.grid.ac/institutes/grid.411477.0 schema:alternateName Azienda Ospedaliera Universitaria Senese
350 schema:name Pediatric Unit, University Hospital, Siena, Italy
351 rdf:type schema:Organization
352 https://www.grid.ac/institutes/grid.412826.b schema:alternateName University Hospital in Motol
353 schema:name Motol University Hospital, Prague, Czech Republic
354 rdf:type schema:Organization
355 https://www.grid.ac/institutes/grid.42399.35 schema:alternateName Centre Hospitalier Universitaire de Bordeaux
356 schema:name CHU Pellegrin–Hôpital des Enfants, Bordeaux, France
357 rdf:type schema:Organization
358 https://www.grid.ac/institutes/grid.427987.7 schema:alternateName Bethesda Gyermekkórház
359 schema:name National Institute of Neurosciences, Budapest, Hungary
360 Neurology Department, Bethesda Children’s Hospital, Bethesda Street 3, H-1146, Budapest, Hungary
361 rdf:type schema:Organization
362 https://www.grid.ac/institutes/grid.476612.0 schema:alternateName Novartis (Spain)
363 schema:name Novartis Farmacéutica SA, Barcelona, Spain
364 rdf:type schema:Organization
365 https://www.grid.ac/institutes/grid.7644.1 schema:alternateName University of Bari Aldo Moro
366 schema:name Neonatology and NICU Section, DIMO, University of Bari, Bari, Italy
367 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...